Agilon Health (NYSE:AGL) Reaches New 12-Month High – Here’s What Happened

Agilon Health, Inc. (NYSE:AGL) shares reached a new 52-week high during trading on Monday . The company traded as high as $119.07 and last traded at $114.2640, with a volume of 23927 shares changing hands. The stock had previously closed at $113.80.

Analyst Ratings Changes

Several equities research analysts have issued reports on AGL shares. Benchmark reissued a “buy” rating and set a $95.00 target price (up from $13.00) on shares of Agilon Health in a research note on Thursday, May 21st. TD Cowen reiterated a “hold” rating and set a $55.00 price target (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Wells Fargo & Company reissued an “overweight” rating and set a $72.00 price objective (up from $37.50) on shares of Agilon Health in a research report on Friday, May 8th. Barclays upgraded shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price objective on the stock in a report on Tuesday, May 26th. Finally, JPMorgan Chase & Co. cut shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price on the stock. in a research report on Monday, May 4th. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Agilon Health has an average rating of “Hold” and an average target price of $58.73.

Agilon Health Trading Up 1.3%

The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08. The company has a market cap of $1.92 billion, a PE ratio of -5.35 and a beta of 3.00. The business has a 50-day simple moving average of $66.92 and a 200-day simple moving average of $34.14.

Agilon Health (NYSE:AGL) last posted its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.76. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. On average, analysts predict that Agilon Health, Inc. will post -3.5 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in AGL. Wealthcare Advisory Partners LLC acquired a new stake in Agilon Health during the 3rd quarter worth approximately $26,000. CIBC Bancorp USA Inc. purchased a new position in Agilon Health in the 3rd quarter valued at approximately $34,000. Tower Research Capital LLC TRC grew its stake in shares of Agilon Health by 214.0% in the second quarter. Tower Research Capital LLC TRC now owns 37,079 shares of the company’s stock worth $85,000 after acquiring an additional 25,270 shares in the last quarter. Prudential Financial Inc. grew its stake in shares of Agilon Health by 70.7% in the second quarter. Prudential Financial Inc. now owns 40,880 shares of the company’s stock worth $94,000 after acquiring an additional 16,928 shares in the last quarter. Finally, LPL Financial LLC increased its position in shares of Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after acquiring an additional 30,000 shares during the period.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.